# IsoTis OrthoBiologics, Inc. – FDA Inspection, Mar 6, 2026

Source: https://www.keypedia.com/records/fda_inspections/isotis-orthobiologics-inc/bd6ba2f2-55e8-4d26-be9d-3ca1afe19b9f
Source feed: FDA_Inspections

> FDA inspection 1306970 of IsoTis OrthoBiologics, Inc., March 06, 2026. 2 citations under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306970
- Company Name: IsoTis OrthoBiologics, Inc.
- Inspection Date: 2026-03-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1290380 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/isotis-orthobiologics-inc/5ef63c88-91ba-4d6f-acd0-719075388556)
- FDA Inspection 1033932 - 2017-11-29
- FDA Inspection 942796 - 2015-09-25
- FDA Inspection 777655 - 2012-04-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)

Company: https://www.keypedia.com/companies/isotis-orthobiologics-inc/df4a7da7-92c2-474d-b810-2ad643c54425

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
